Humana Inc. (NYSE:HUM) Shares Sold by Plato Investment Management Ltd

Plato Investment Management Ltd decreased its position in shares of Humana Inc. (NYSE:HUM) by 2.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,767 shares of the insurance provider’s stock after selling 51 shares during the period. Plato Investment Management Ltd’s holdings in Humana were worth $559,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV grew its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. grew its position in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares during the last quarter. Atwood & Palmer Inc. acquired a new position in Humana in the third quarter valued at $29,000. Ashton Thomas Securities LLC purchased a new stake in shares of Humana in the third quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP boosted its stake in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $282.97 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18. The company has a market capitalization of $34.07 billion, a P/E ratio of 25.06, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a 50-day moving average price of $284.64 and a two-hundred day moving average price of $332.14.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, research analysts expect that Humana Inc. will post 15.83 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HUM. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Royal Bank of Canada dropped their target price on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. TD Cowen increased their price target on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and lowered their price objective for the company from $519.00 to $253.00 in a research report on Monday, October 7th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.